DarioHealth Corp (DRIO)

DarioHealth Corp. is a healthcare technology company listed on NASDAQ under the ticker DRIO. The company develops a digital health platform that combines data analytics with personalized interventions and one-on-one coaching. Its solutions are designed to support users managing diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. DarioHealth’s product set includes Dario Connect, which is intended to build communities around specific health conditions; Dario Mind, a behavioral health offering focused on stress, anxiety, and depression; Dario Move, which addresses posture-related pain; and Dario Health, a self-care and virtual coaching application that also covers diabetes, hypertension, weight management, and GLP-1-related support. The company also sells bundled subscription packages, either as a full suite or through partial suite arrangements. Formerly known as LabStyle Innovations Corp., the company adopted its current name in July 2016 and was incorporated in 2011. It is headquartered in New York, New York, and operates in the United States, Canada, the European Union, Australia, and New Zealand.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.